月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE(每份年报一根整柱,柱宽 = 生效期:报告期 + 4 个月起)
加载中…
获利能力 Profitability (单位:美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | 14.97% | 17.19% | 20.91% | 21.15% | 19.85% | 17.14% | 22.81% | 24.69% | 21.55% | 25.77% | 26.65% | 7.18% | 44.48% | 70.73% | 76.13% | 73.16% | 126.47% | 135.79% | 67.55% | 106.10% | 47.53% | 41.23% |
| 总资产收益率(ROA) | 8.73% | 9.14% | 11.12% | 11.62% | 10.64% | 7.54% | 8.00% | 7.68% | 7.47% | 9.71% | 9.95% | 2.48% | 12.64% | 13.13% | 11.54% | 9.63% | 10.06% | 6.91% | 4.45% | 8.51% | 3.60% | 4.39% |
| 毛利率 | 85.32% | 82.75% | 84.70% | 85.72% | 85.25% | 82.62% | 81.47% | 82.08% | 77.96% | 80.49% | 81.90% | 82.19% | 82.73% | 81.35% | 75.77% | 75.16% | 75.66% | 70.02% | 61.53% | 67.25% | 65.50% | 70.25% |
| 净利率 | 20.68% | 21.43% | 27.01% | 31.45% | 30.74% | 23.64% | 25.17% | 27.21% | 25.71% | 32.03% | 33.59% | 8.66% | 35.35% | 33.57% | 28.57% | 22.68% | 24.89% | 23.83% | 12.24% | 20.98% | 18.25% | 22.46% |
| 每股收益(EPS) | 2.51 | 2.83 | 3.79 | 4.53 | 4.82 | 4.07 | 5.61 | 6.75 | 6.80 | 9.15 | 10.32 | 2.71 | 12.70 | 12.96 | 12.40 | 10.34 | 12.18 | 12.56 | 7.62 | 14.33 | 5.88 | 7.77 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | 3.80% | 5.84% | 4.87% | 7.28% | 7.56% | 14.21% | 6.00% | 5.75% | 5.41% | 5.80% | 4.18% | 4.75% | 10.46% | 10.11% | 9.95% | 13.06% | 11.72% | 11.26% | 13.04% | 10.08% | 9.13% | 14.63% |
| 负债占总资产比率 | 43.87% | 48.41% | 42.67% | 42.80% | 44.94% | 61.06% | 64.90% | 66.58% | 62.65% | 60.70% | 61.51% | 68.43% | 81.18% | 83.80% | 85.05% | 89.05% | 94.38% | 93.59% | 93.60% | 90.44% | 91.55% | 87.78% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | 6.52 | 6.81 | 7.08 | 6.80 | 6.28 | 5.28 | 6.61 | 6.75 | 7.59 | 6.99 | 6.92 | 6.73 | 6.29 | 5.47 | 5.36 | 4.96 | 4.46 | 3.70 | 4.72 | 3.67 | 1.91 | 1.74 |
| 平均收现日数 | 56 天 | 54 天 | 52 天 | 54 天 | 58 天 | 69 天 | 55 天 | 54 天 | 48 天 | 52 天 | 53 天 | 54 天 | 58 天 | 67 天 | 68 天 | 74 天 | 82 天 | 99 天 | 77 天 | 99 天 | 191 天 | 210 天 |
| 固定资产周转率(次) | 0.4273 | 0.4151 | 0.4003 | 0.3998 | 0.3767 | 0.3544 | 0.3201 | 0.2940 | 0.2702 | 0.2343 | 0.2266 | 0.2289 | 0.2200 | 0.2219 | 0.2017 | 0.2134 | 0.2188 | 0.2208 | 0.2043 | 0.2251 | 0.4119 | 0.4814 |
| 总资产周转率 | 41.01% | 41.31% | 40.32% | 36.21% | 33.71% | 31.30% | 30.64% | 27.51% | 28.01% | 29.31% | 28.20% | 27.26% | 33.93% | 37.19% | 38.51% | 39.72% | 38.08% | 27.70% | 34.87% | 38.80% | 18.94% | 18.56% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | 12.83 | 20.24 | 17.74 | 28.84 | 32.87 | 69.46 | 32.57 | 38.05 | 37.31 | 41.44 | 32.41 | 38.00 | 69.45 | 60.37 | 62.66 | 79.89 | 76.29 | 109.44 | 119.73 | 91.29 | 80.28 | 139.89 |
| 净利润 | 29.50 | 31.66 | 40.52 | 46.05 | 46.27 | 36.83 | 43.45 | 50.81 | 51.58 | 69.39 | 77.22 | 19.79 | 83.94 | 78.42 | 72.64 | 58.93 | 65.52 | 67.17 | 40.90 | 77.11 | 31.62 | 41.94 |
| 经营活动现金流量 | 53.89 | 54.01 | - | 63.36 | 57.87 | 51.19 | 58.82 | 62.91 | 89.52 | 97.31 | 103.54 | 111.77 | 112.96 | 91.50 | 104.97 | 92.61 | 97.21 | 84.71 | 114.90 | 99.58 | 36.71 | 61.91 |
| 投资活动现金流量 | -51.31 | -19.92 | - | -32.02 | -41.52 | -7.86 | -99.90 | -84.69 | -57.52 | -55.47 | -86.58 | -40.24 | 143.39 | 57.09 | -54.01 | 7.33 | -60.44 | -262.04 | -10.46 | -19.43 | -8.36 | -12.85 |
| 筹资活动现金流量 | -8.15 | -26.68 | - | -20.24 | -12.32 | -6.74 | 4.19 | 27.26 | -32.74 | -37.71 | -25.99 | -65.94 | -224.90 | -157.67 | -48.67 | -82.71 | -40.37 | 210.48 | -94.15 | -108.59 | -67.80 | -0.46 |
| 净现金流量 | -5.57 | 7.41 | - | 11.10 | 4.03 | 36.59 | -36.89 | 5.48 | -0.74 | 4.13 | -9.03 | 5.59 | 31.45 | -9.08 | 2.29 | 17.23 | -3.60 | 33.15 | 10.29 | -28.44 | -39.45 | 48.60 |
右侧两列为报告期累计口径同比(左:去年同期同一期次,右:最近一期季报,年报期次已在左侧列展示);周转率类指标为报告期累计值,未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD